Sponsor Pipeline

Hangzhou PhecdaMed Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
1
Phase 3
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-06 NCT07620938
Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia		 Recruitment opened
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-08-03 NCT07741045 Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients… Phase 3 Not Yet Recruiting
Active Trials by Phase
Phase 3
1
Phase 2
2
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07741045 Phase Ⅲ Clinical Trial to Evaluate the Efficacy and Safety of TJ0113 Capsules in Patients… Parkinson's Disease (PD) Not Yet Recruiting
Phase 2
NCT07018245 Clinical Trial of TJ0113 Capsules in the Treatment of Patients With Depressive Disorder Depression Recruiting
NCT07620938 Clinical Study of TJ0113 Capsule in the Treatment of Patients With Sarcopenia Sarcopenia Recruiting
Disease Areas
Depression (1) Parkinson's Disease (1)
Get alerts when Hangzhou PhecdaMed Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free